Pharmaceutical research and bio-technology are long term investments that are not traditionally associated with small entrepreneurs
Pharmaceutical research and bio-technology are long term investments that are not traditionally associated with small entrepreneurs. The growth of Yokneam's Startup Village ecosystem attracted high-tech incubators and other sources of funding for Yokneam's budding pharma and bio-tech industry.
Cytora has developed a revolutionary technology to produce “off-the-shelf” (allogeneic) therapeutic doses of hOMSC to treat some of the most challenging diseases of this decade including chronic wounds such as diabetic foot ulcers (DFU) autoimmune and degenerative diseases such as Parkinson’s Disease, Multiple System Atrophy (MSA), and Alzheimer’s Disease.
It is a known fact that one in 25 patients contracts a healthcare-related bacterial infection during a hospital stay. Using our unique patented process and materials to achieve a long term antibacterial and antibiofilm properties, we have successfully achieved up to 8 log reduction of MARSA, KPC, E. Coli and other resistant bacteria – within minutes. Because the mode of operation is not based on leaching of the coating, we are able to achieve high antibacterial efficacy, over a long period of time.
NanoSono Ltd. (NSC Ltd.) is in the key position to offer a cost-effective solution to a soon-to-be standardized market. In the near future, medical devices, fabrics that are potentially infection causes will require to gain anti-bacterial capabilities to be allowed within patient environments. The most effective way to protect the patients’ and the staffs’ environment is by avoiding the infection in the first place, preferably by eradicating the bacteria from the devices and the equipment that comes in contact with the patients and the hospital stuff. In addition, we make sure the patients’ environment, such as operating rooms, is as sterile as possible, we are also focused on lowering the risk of infection by making “carrier” materials within the patients’ direct environment such as robes, linens etc. anti-bacterial.
NanoSpun develops and produces smart fibrous mats and surfaces which significantly improve biological processes. NanoSpun utilizes its proprietary nanotechnology, impressively controlled over the fiber properties and unique embodiment capabilities, to encapsulate designated active microorganisms within its fibrous permeable structures.
NanoSpun solution offers fundamental advantages over other competing technologies and its resulting products demonstrate efficient, cost-effective and easy to operate solutions which represent leapfrog advancement for humankind and sustainable environment.
NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.
Bringing the World Better Nutrition
The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value. At Nextferm, we aim to use our capabilities to lead this new and exciting world of better nutrition.
Foodtech startup for production of natural food colorants.
Phytolon’s activity consists at developing a novel technology for the production of pure, stable, cheap and healthy natural food colorants by fermentation. With this technology, we offer an appropriate substitute for the harmful synthetic colorants and for the currently used insufficient natural colorants.
Phytolon operates as a portfolio company of the Trendlines incubator, and is funded by the Israeli Innovation Authority since August 2018.
Vivox, experts in vivo, is one of the leading CROs in Israel. Our passion and specialty are supporting pharmaceutical-oriented companies in their preclinical research stages.
We provide professional preclinical services designed and performed by our experts to help a range of industries cross their preclinical stages.
We are honored to share our preclinical services and knowledge, both in-vivo and in-vitro, with our clients to advance potential new therapies towards clinical stages and beyond.
For the past decade, Bara Herbs has been the leader of the future herbal medicine, through means of research and development, production, marketing and the setting up of a knowhow center for professionals. Bara's herbal products are well known for their therapeutic creativity and the highest quality of raw materials. The company specializes in the extraction and processing of more than 700 quality medicinal herbs from Israel and around the world.
The development of Bara's herbal products is based on extensive clinical experience, scientific research collaborations and most innovative production technologies – all of which guarantee the purest, whole extraction of each herb, upon its full spectrum of bioavailable constituents. Bara's herbal-based products are easy to integrate into the daily routine as they are available in various forms including tinctures, capsules, tablets, teas, syrups, ointments and oils.